Valuation: Chongqing Jiheng Pharmaceutical Co., Ltd.

Market Cap 2.92B 433M 374M 352M 320M 601M 41.41B 611M 4.12B 1.61B 20.74B 1.63B 1.59B 68.92B P/E 2024
-2.74x
P/E 2025 -7.41x
Enterprise Value 3.33B 494M 427M 401M 365M 686M 47.25B 697M 4.7B 1.84B 23.66B 1.86B 1.81B 78.63B EV / Sales 2024
2.87x
EV / Sales 2025 3.89x
Free-Float
54.43%
Yield 2024 *
-
Yield 2025 -
08-14 Chongqing Jiheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
04-24 Chongqing Jiheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-29 Chongqing Sansheng Industrial Co.,Ltd. agreed to acquire an additional 11.94% stake in Chongqing Chunrui Pharmaceutical and Chemical Co., Ltd. from Hao Tingyan. CI
03-16 Chongqing Jiheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
25-10-28 Chongqing Jiheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-08-26 Chongqing Jiheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-07-03 Zhang Yanning and Cen Yetao completed the acquisition of 7.45% stake in Chongqing Sansheng Industrial Co.,Ltd. from Pan Xianwen for approximately CNY 110 million. CI
25-07-01 Zhang Yanning and Cen Yetao agreed to acquire 7.45% stake in Chongqing Sansheng Industrial Co.,Ltd. from Pan Xianwen for approximately CNY 110 million. CI
25-07-01 Zhang Yanning and Cen Yetao agreed to acquire 7.45% stake in Chongqing Sansheng Industrial Co.,Ltd. from Pan Xianwen for approximately CNY 110 million. CI
25-04-25 Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-04-25 Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-04-24 Chongqing Sansheng Industrial Co.,Ltd. Auditor Raises 'Going Concern' Doubt CI
24-10-29 Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024 CI
1 day-1.84%
1 week+3.39%
Current month+22.00%
1 month+18.94%
3 months-11.04%
6 months+1.43%
Current year-5.53%
1 week 4.05
Extreme 4.05
4.53
1 month 3.18
Extreme 3.18
4.53
Current year 3.18
Extreme 3.18
5.26
1 year 3.18
Extreme 3.18
5.45
3 years 1.24
Extreme 1.24
6.09
5 years 1.24
Extreme 1.24
7.83
10 years 1.24
Extreme 1.24
31.05
Manager TitleAgeSince
Chief Executive Officer 59 2010-02-28
Director of Finance/CFO 52 2023-04-20
Chief Tech/Sci/R&D Officer 49 -
Director TitleAgeSince
Director/Board Member 54 2019-09-26
Director/Board Member 74 -
Director/Board Member 69 2019-09-26
Change 5-day change 1-year change 3-year change Capi.($)
-1.84%+3.39%-14.94%+9.77% 441M
-2.25%-0.47%+72.43%+119.36% 1,078B
-0.66%+0.43%+49.01%+50.11% 632B
-0.54%+1.39%+21.88%+63.83% 443B
-1.99%-3.32%+41.98%+34.08% 356B
-1.05%-2.81%+24.22%+34.67% 289B
-2.12%-3.67%-1.09%+3.11% 245B
-0.63%+1.04%+43.03%+59.10% 226B
-1.19%-3.41%-9.18%-52.41% 204B
+0.16%+3.87%+16.25%+73.27% 171B
Average -0.78%+0.30%+24.36%+39.49% 364.41B
Weighted average by Cap. -0.08%+0.31%+41.44%+62.22%

Financials

2024 2025
Net sales 1.2B 177M 153M 144M 131M 246M 16.95B 250M 1.69B 659M 8.49B 666M 651M 28.21B 900M 133M 115M 108M 98.48M 185M 12.76B 188M 1.27B 496M 6.39B 501M 490M 21.23B
Net income -650M -96.39M -83.25M -78.23M -71.15M -134M -9.22B -136M -917M -358M -4.62B -362M -354M -15.34B -420M -62.22M -53.74M -50.5M -45.93M -86.35M -5.95B -87.77M -592M -231M -2.98B -234M -229M -9.9B
Net Debt 1.66B 246M 213M 200M 182M 342M 23.55B 347M 2.34B 916M 11.8B 925M 905M 39.2B 412M 61.03M 52.71M 49.53M 45.05M 84.69M 5.84B 86.09M 580M 227M 2.92B 229M 224M 9.71B
Logo Chongqing Jiheng Pharmaceutical Co., Ltd.
Chongqing Jiheng Pharmaceutical Co Ltd, formerly Chongqing Sansheng Industrial Co Ltd is a China-based company primarily engaged in building materials and chemical, and pharmaceutical manufacturing businesses. The Company operates two main businesses. The building materials and chemical business is primarily engaged in the production and sales of ready-mixed concrete, water-reducing agents, expanding agents and sulfuric acid. The pharmaceutical manufacturing business is primarily engaged in the production and sales of pharmaceutical intermediates such as procaine hydrochloride and cefoxitin intermediates, active pharmaceutical ingredients (APIs) such as acetaminophen and clopidogrel hydrochloride, and pharmaceutical preparations such as compound acetaminophen and diphenhydramine tablets, and clopidogrel hydrochloride tablets. The Company conducts its businesses in the domestic market and overseas markets.
Employees
979
Date Price Change Volume
26-08-14 CN¥4.270 -1.84% 20,876,900
26-08-13 CN¥4.350 -1.36% 27,773,600
26-08-12 CN¥4.410 +3.28% 42,594,635
26-08-11 CN¥4.270 -0.93% 48,121,064
26-08-10 CN¥4.310 +4.36% 70,262,654
  1. Stock Market
  2. Stocks
  3. 002742 Stock